CurrentPartnering: Market Research Reports

... companies. Trends in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active deal makers Financial deal terms for bioinformatics The Global Bioinformatics Partnering Terms and Agreements 2014 ...

... DESCRIPTION Global Hematology Partnering 2014 to 2019 provides the full collection of Hematology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Hematology partnering deals Financial deal terms ...

... DESCRIPTION Global Genitourinary Partnering 2014 to 2019 provides the full collection of Genitourinary disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Genitourinary partnering deals Financial deal terms ...

... scope Global Gynecology Partnering 2014 to 2019 is intended to provide the reader with an in-depth understanding and access to Gynecology trends and structure of deals entered into by leading companies worldwide. Global Gynecology Partnering 2014 to 2019 ...

... DESCRIPTION Global Immunology Partnering 2014 to 2019 provides the full collection of Immunology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Immunology partnering deals Financial deal terms ...

... access to Genetic Disorders trends and structure of deals entered into by leading companies worldwide. Global Genetic Disorders Partnering 2014 to 2019 includes: Trends in Genetic Disorders dealmaking in the biopharma industry since 2014 Analysis of Genetic Disorders deal structure ...

... access to Hospital Care trends and structure of deals entered into by leading companies worldwide. Global Hospital Care Partnering 2014 to 2019 includes: Trends in Hospital Care dealmaking in the biopharma industry since 2014 Analysis of Hospital Care deal structure ...

... access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies. DESCRIPTION The Global Regenerative Medicine Partnering 2014-2019: Deal trends, players ...

... Access to over 640 monoclonal antibodies deal records The leading monoclonal antibodies deals by value since 2014 Includes chimeric mAb, humanized mAb, human mAb and murine mAb deals and alliances since 2014 In Global Monoclonal antibody Partnering Terms and Agreements 2014 to 2098 ...

... imaging partnering deals. This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering: Imaging CT Endoscope Molecular and nuclear PET SPECT MRI Ultrasound X ray Angiography Fluoroscopy Mammography This report provides an overview of diagnostic imaging ...

... -life gene therapy deals Access to over 220 gene therapy deals The leading gene therapy deals by value since 2014 Most active gene therapy dealmakers since 2014 The leading gene therapy partnering resources In Global Gene Therapy Partnering Terms and ...

... due diligence to assess suitability of your proposed deal terms for partner companies Report scope Global Molecular Diagnostics Partnering 2014-2019: Deal trends, players, financials and forecasts is intended ...

... , upfronts, milestones and royalties by stage of development Genomics partnering contract documents Top Genomics deals by value The Global Genomics Partnering Terms and Agreements report provides an understanding and ...

... , upfronts, milestones and royalties by stage of development Microbiome partnering contract documents Top Microbiome deals by value The Global Microbiome Partnering Terms and Agreements report provides an understanding and ...

... , upfronts, milestones and royalties by stage of development Proteomics partnering contract documents Top Proteomics deals by value The Global Proteomics Partnering Terms and Agreements report provides an understanding and ...

... fifty big pharma companies Understand the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies

SUMMARY The Global COVID-19 Partnering report provides comprehensive understanding and unprecedented access to the COVID-19 partnering deals and agreements entered into by the worlds leading healthca...

... Case studies of real-life Companion Diagnostics deals Access to Companion Diagnostics contract documents Leading Companion Diagnostics deals by value since 2014 Most active Companion Diagnostics dealmakers since 2014 In Global Companion Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...

... announced in the healthcare sectors, covering: Antibodies Antibody-drug conjugates Monoclonal antibodies Murine mAb Chimeric mAb Humanized mAb Human aAb Polyclonal Antibodies Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process ...

... access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies DESCRIPTION Global Infectious Diseases Partnering 2014 to 2019 provides the full collection of Infectious Diseases disease deals signed between ...

... DESCRIPTION Global Metabolic Partnering 2014 to 2019 provides the full collection of Metabolic disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Metabolic partnering deals Financial deal terms ...

... DESCRIPTION Global Musculoskeletal Partnering 2014 to 2019 provides the full collection of Musculoskeletal disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Musculoskeletal partnering deals Financial deal terms ...

... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...

... healthcare sectors, covering: Antibiotics Aminoglycosides Cephalosporin Clindamycin Macrolides Penicillin Quinolones Sulfonamides Tetracycline Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into ...

... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

... to hundreds of Orphan Diseases deal contract documents Comprehensive access to over 120 Orphan Diseases deal records The leading Orphan Diseases deals by value since 2014 Most active Orphan Diseases dealmakers since 2014 In Global Orphan Diseases Partnering 2014 to 2019, available deals and ...

... cancer monoclonal antibody deals by value since 2014 In Cancer Monoclonal Antibody Partnering Terms & Agreements, the available deals are listed by: Company A-Z Headline value Stage of development at signing Deal component type Specific oncology ...

... healthcare sectors, covering: Companion Diagnostics Imaging CT Endoscope Molecular and nuclear MRI Ultrasound X-ray PET SPECT Angiography Fluroscopy Mammography In vitro diagnostics Molecular diagnostics Prognostics Theranostics The report provides a detailed ...

... by the big pharma and big biotech companies of the world in terms of deals made. One of the key highlights of the report is that over 450 online deals records of actual vaccine deals ...

... Drug Delivery deals Access to Drug Delivery contract documents Leading Drug Delivery deals by value since 2014 Most active Drug Delivery dealmakers since 2014 In Global Drug Delivery Partnering 2014-2019: Deal ... at signing Deal component type Specific therapy target Technology type Each deal title links ...

... 250 infectious vaccines deal records Identify the most active infectious vaccine dealmakers since 2014 The leading infectious vaccines deals by value since 2014 Includes adjuvant deals and alliances since 2014 In Global Infectious Vaccines Partnering Terms ...

... of real-life In Vitro Diagnostics deals Access to In Vitro Diagnostics contract documents Leading In Vitro Diagnostics deals by value since 2014 Most active In Vitro Diagnostics dealmakers since 2014 In Global In Vitro Diagnostics Partnering 2014-2019: Deal trends, players ...

... Case studies of real-life Stem Cell deals Access to Stem Cell contract documents Leading Stem Cell deals by value since 2014 Most active Stem Cell dealmakers since 2014 In Global Stem Cell Partnering 2014-2019: Deal trends, players, financials and ...

... 200 artificial intelligence deals The leading artificial intelligence deals by value since 2014 Most active artificial intelligence dealmakers since 2014 The leading artificial intelligence partnering resources In Global Artificial Intelligence Partnering Terms and ...

... unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies DESCRIPTION The Global Precision Medicine Partnering 2014-2019 report provides comprehensive understanding ...

... the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies REPORT SCOPE Global Asset Purchase Deals in Pharma, Biotech and ...

... heart failure, Coronary artery disease, Ductus arteriosus, Fatigue, Hypercholesterolemia, Hypertension, Intermittent claudication, Ischemic heart disease, Limb ischemia, Marfan's Syndrome, Myocardial Infarction, Oedema (excess fluid), Palpitations, Peripheral arterial disease, Thrombus (blood clot), Valvular ...

... Cerebral palsy, Creutzfeldt Jakob disease, Dizziness, Epilepsy, Faints, Falls, Guillain Barre syndrome, Headache, Meningitis (Bacterial, Meningococcal, Pneumococcal), Mycobacterium tuberculosis (TB), Haemophilus influenzae Type B (Hib), Migraine, Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig ...

... DESCRIPTION Global Dental Partnering 2014 to 2019 provides the full collection of Dental disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Dental partnering deals Financial deal terms ...

... , Esophagitis, Gastritis, Gastroenteritis, Hemorrhoids (haemorrhoids), Hernia, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Irritable bowel syndrome, Malabsorption, Malnutrition, Pancreatitis, Peptic ulce, Gastric ulcer, Duodenal ulcer, Abdominal pain, Ascites, Bowel movement, Constipation ...

... deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles ...

... manufacturing and supply deals by value since 2014 Most active manufacturing and supply dealmakers since 2014 The leading manufacturing and supply partnering resources In Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech ...

... Current Agreements deals and alliances database, providing easy access to each deal record on demand. The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 ...

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

... DESCRIPTION The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and ...

... Joint venture alliances. KEY BENEFITS Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 provides the reader with the following key benefits: In-depth understanding of joint venture partnering deal ...

... latest licensing agreements announced in the pharmaceutical, biotechnology ... licensing deals by value since 2014 Most active licensing dealmakers since 2014 The leading licensing partnering resources In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals ...

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...